IndraLab

Statements


USP14 activates MAPT. 8 / 8
| 1 7

eidos
"13 IU1 , an inhibitor of USP14 , can increase UPS activities , promote Tau degradation , and enhance mitochondrial elimination in neuronal cells.14 , 15 , 16 Similarly , dysregulation of USP14 has been reported in several tumors , including breast cancer , lung adenocarcinoma , and epithelial ovarian cancer.17 , 18 , 19 However , whether USP14 is involved in preeclampsia remains elusive ."

reach
"Intriguingly, Lee et al. demonstrated that IU1, a selective small-molecule inhibitor of USP14, accelerated proteasomal degradation of tau and TDP-43, which have been implicated in neurodegenerative diseases XREF_BIBR."

reach
"Knockdown of USP14 also marginally reduced tau (Figure S1A and S1B), consistent with USP14 aptamers enhancing tau degradation through the proteasome (Lee et al., 2015)."

reach
"In agreement with the function of USP14, we observed that coexpression of USP14-WT resulted in the elevated levels of both the longest isoform of human MAPT (MAPT-WT) and its aggregation-prone P301L m[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"192 Conversely, IU1, a small molecule inhibitor of USP14, stimulated the degradation of tau."

reach
"Moreover, IU1-47, a small molecule inhibitor of USP14, was also shown to accelerate the degradation of tau protein (Table 2) (Boselli et al., 2017)."

reach
"This result is also consistent with Boselli et al.’s observation that USP14 inhibition enhances tau degradation in cultured neurons [213]."
| PMC

reach
"Although pharmacological inhibitors of USP14's ubiquitin-hydrolase activity reduced microtubule associate protein tau, tar DNA binding protein, and prion protein in culture, the effect was similar in wild type and USP14-deficient neurons, thus impacting their use for specifically evaluating USP14 in a therapeutic manner."